Prioritizing metastatic non-small cell lung cancer launch and focusing research and development activities in areas of greatest anticipated value creation Expected reduction in residual operating ...

For more than 25 years NICE has helped practitioners and commissioners get the best care to people, fast, while ensuring value for the taxpayer. Until recently, we prioritised guidance through several ...

For 25 years NICE has acted as a trusted guide in health and care. We’ve provided health and care practitioners and commissioners with advice on the most clinically and cost-effective treatments, ...